✦ LIBER ✦

Disease-modifying trial in Alzheimer's Disease (AD): What should be the place of cognitive testing?

✍ Scribed by Jacques Touchon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-cognitive outcomes in trials of dise

✍ D. Zekry; C.E. Graf; S.V. Giannelli; G. Gold; J.-P. Michel 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 288 KB

Disease modifying effects of mifepriston

✍ Vargas, David Baglietto; Green, Kim N.; Medeiros, Rodrigo; Martinez-Coria, Hilda 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Cognitive evaluation of disease-modifyin

✍ Debby Van Dam; Katrien Coen; Peter Paul De Deyn 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 159 KB

Oxidatively modified proteins in Alzheim

✍ Rukhsana Sultana; Marzia Perluigi; D. Allan Butterfield 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 799 KB

P4-387: Adding delayed recall to the Alz

✍ Raman, Rema; Emond, Jennifer; Thomas, Ronald G.; Petersen, Ronald C.; Schneider, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 102 KB

What Can Be Inferred from the Interrupti

✍ Jeffrey Cummings 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 101 KB